JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 19, 2006; DOI: 10.1124/jpet.105.100081


0022-3565/06/3182-899-906$20.00
JPET 318:899-906, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.100081v1
318/2/899    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinez, J. M.
Right arrow Articles by Eling, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinez, J. M.
Right arrow Articles by Eling, T. E.

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

Drug-Induced Expression of Nonsteroidal Anti-Inflammatory Drug-Activated Gene/Macrophage Inhibitory Cytokine-1/Prostate-Derived Factor, a Putative Tumor Suppressor, Inhibits Tumor Growth

Jeanelle M. Martinez, Tina Sali, Ryuji Okazaki, Colleen Anna, Melinda Hollingshead, Curtis Hose, Anne Monks, Nigel J. Walker, Seung Joon Baek, and Thomas E. Eling

Laboratories of Molecular Toxicology (J.M.M.) and Toxicology Operations Branch (N.J.W.) and Molecular Carcinogenesis (T.S., R.O., C.A., S.J.B., T.E.E.) National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina; SAIC-Frederick, Inc., Screening Technologies Branch, Laboratory of Functional Genomics, National Cancer Institute, Frederick, Maryland (M.H.,C.H., A.M.); National Decontamination Team, Office of Solid Waste and Emergency Response, Environmental Protection Agency, Cincinnati, Ohio (J.M.M.); Department of Pathobiology, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee (S.J.B.); and Department of Radiation Biology and Health, School of Medicine, University of Occupational and Environmental Health Kitakyushu, Japan (R.O.)

A common in vitro response for many chemopreventive and antitumor agents, including some cyclooxygenase inhibitors, is the increased expression of nonsteroidal anti-inflammatory drug-activated gene (NAG)-1/macrophage inhibitory cytokine (MIC)-1/prostate-derived factor (PDF). The experimental anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F203) was a potent inducer of NAG-1 expression, and in MCF-7 cells, it inhibited cell growth and induced apoptosis. NAG-1 small interfering RNA blocked NAG-1 expression and 5F203-induced apoptosis in MCF-7 cells, indicating that NAG-1 may mediate the apoptosis and anticancer activity. One mechanism by which 5F203 increases NAG-1 expression is by increasing the stability of NAG-1 mRNA, dependent of de novo protein synthesis. Extracellular signal-regulated kinase (ERK) 1/2 phosphorylation was increased by 5F203, and inhibition of ERK1/2 phosphorylation abolished the induction of NAG-1 protein expression and increased the stability of NAG-1 mRNA. Thus, 5F203 regulates NAG-1 expression by a unique mechanism compared with other drugs. A mouse orthotopic mammary tumor model was used to determine whether 5F203 increased NAG-1 expression in vivo and suppressed tumor growth. Treatment of the mice with Phortress, the prodrug of 5F203, increased the in vivo expression of NAG-1 as measured by real-time reverse transcription-polymerase chain reaction from RNA obtained by needle biopsy, and the expression correlated with a reduction of tumor volume. These results confirm that NAG-1 suppresses tumor growth, and its in vivo expression can be controlled by treating mice with anticancer drugs, such as Phortress. Drugs that target NAG-1 could lead to a unique strategy for the development of chemotherapeutic and chemopreventive agents.


Received for publication December 16, 2005
Accepted May 15, 2006.

Address correspondence to: Dr. Thomas E. Eling, Laboratory of Molecular Carcinogenesis, 111 T.W. Alexander Dr., P.O. Box 12233, MD E4-09, Research Triangle Park, NC 27709. E-mail: eling{at}niehs.nih.gov




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Yoshioka, H. Kamitani, T. Watanabe, and T. E. Eling
Nonsteroidal Anti-inflammatory Drug-activated Gene (NAG-1/GDF15) Expression Is Increased by the Histone Deacetylase Inhibitor Trichostatin A
J. Biol. Chem., November 28, 2008; 283(48): 33129 - 33137.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Shim and T. E. Eling
Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism
Mol. Cancer Ther., April 1, 2008; 7(4): 961 - 971.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y.-L. Chen, P.-C. Lin, S.-P. Chen, C.-C. Lin, N.-M. Tsai, Y.-L. Cheng, W.-L. Chang, S.-Z. Lin, and H.-J. Harn
Activation of Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1 via Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Revealed a Isochaihulactone-Triggered Apoptotic Pathway in Human Lung Cancer A549 Cells
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 746 - 756.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C.-Y. Huang, T. M. Beer, C. S. Higano, L. D. True, R. Vessella, P. H. Lange, M. Garzotto, and P. S. Nelson
Molecular Alterations in Prostate Carcinomas that Associate with In vivo Exposure to Chemotherapy: Identification of a Cytoprotective Mechanism Involving Growth Differentiation Factor 15
Clin. Cancer Res., October 1, 2007; 13(19): 5825 - 5833.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. S. Selander, D. A. Brown, G. B. Sequeiros, M. Hunter, R. Desmond, T. Parpala, J. Risteli, S. N. Breit, and A. Jukkola-Vuorinen
Serum Macrophage Inhibitory Cytokine-1 Concentrations Correlate with the Presence of Prostate Cancer Bone Metastases
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 532 - 537.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.